Refractory Hodgkin Lymphoma

Explore clinical trials studying Refractory Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

34 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Refractory Hodgkin Lymphoma trial results

Active, Not Recruiting

NCT01703949

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Active, Not Recruiting

NCT03057795

Conditions: Classic Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
Locations: City of Hope Medical Center Duarte, California, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

Memorial Sloan Kettering Cancer Center New York, United States

Active, Not Recruiting

NCT04134325

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

Active, Not Recruiting

NCT04938232

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations: University of Chicago Medicine Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States